The European trade body for manufacturers and distributors of formula diet products, including total diet replacement products (TDRs) and meal replacement products (MRPs) which provide weight loss and weight management programmes for the overweight and obese. Our members currently operate predominantly in the Netherlands, Sweden, Finland, the Czech Republic, the United Kingdom, Denmark, Ireland, Cyprus, Greece and Poland.
We work to secure appropriate and proportionate European legislation for slimming foods and are in close continuous dialogue with a wide variety of stakeholders such as policymakers and senior officials in the relevant bodies to do this. We also aim to increase awareness and understanding of specialist weight management foods such as TDRs and MRPs and coordinate detailed technical and regulatory expertise of members to develop common industry positions that help to support European public policy and regulatory decisions.
Also to the mainstream press and the specialist media, highlighting the increasing evidence base within the scientific literature regarding their efficacy and potential to change the face of obesity and related diseases in Europe.
All TDMR Europe members abide by our strict Code of Conduct, which can be accessed here.
The World Health Organization recently described obesity as a global epidemic and one of society’s “most blatantly visible yet neglected public health problems”. Recent reports on the rise of this life-threatening condition across the globe have been shocking. A total of 107.7 million children and 603.7 million adults were considered
The argument for Total Diet Replacements In the United Kingdom, the number of people with type 2 diabetes has doubled to 3.8 million in the last 20 years. In just 5 years’ time more than 5 million people will be affected. Diabetes care costs account for about 10% of the
Total Diet Replacement proven to be effective in insulin-treated type 2 diabetes TDMR Europe welcomes the publication of a clinical trial that confirms that total diet replacement (TDR) can be used safely and effectively in people with more advanced insulin-treated diabetes as well as those with early diabetes who can